Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Cardiac Resynchronization Therapy on Skeletal Muscle Histology, Neuroendocrine Activation and Inflammatory Response

NCT01019915 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT01019915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01019915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Cardiac Resynchronization Therapy on Skeletal Muscle Histology, Neuroendocrine Activation and Inflammatory Response
Lead sponsor
Helse Stavanger HF
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
November 30, 2009
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skeletal muscle changes after crt